Physician profile
Ryan Campbell
NPI 1518537331
$1,709.22
in general payments reported to CMS, 2019-2025
16 companies · $761 in 2025
The $761 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.56 · 2022: $247 · 2023: $325 · 2024: $335 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.32 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $255.51 | 2025 | Clareon, Rocklatan, Tryptyr |
| Harrow Eye, LLC | $232.39 | 2024-2025 | Vevye |
| Bausch & Lomb Americas INC. | $175.23 | 2022-2025 | Xiidra, Envista Mx60 Iol, Vyzulta |
| Novartis Pharmaceuticals Corporation | $161.76 | 2021-2023 | |
| Sight Sciences, INC. | $158.51 | 2023 | Omni Surgical System, Tearcare System |
| Dompe US, INC. | $140.53 | 2024-2025 | Oxervate |
| Rxsight INC | $140.41 | 2024-2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Oyster Point Pharma, INC. | $100.08 | 2022-2024 | Tyrvaya |
| Ani Pharmaceuticals, INC. | $87.35 | 2024-2025 | Purified Cortrophin Gel |
| Thea Pharma INC. | $64.13 | 2023-2025 | Iyuzeh |
| Sun Pharmaceutical Industries INC. | $61.27 | 2021-2023 | Cequa |
| Tarsus Pharmaceuticals, INC. | $50.64 | 2024-2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $29.45 | 2021-2022 | |
| Biotissue Holdings INC. | $21.33 | 2022 | |
| Coopervision INC. | $16.71 | 2024 | Paragon Crt |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $13.92 | 2023 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.